Drug intelligence / Profile preview

Visine A.C.

Development stage
Unknown
Lead developer
Johnson & Johnson
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Visine A.C. is an over-the-counter ophthalmic solution developed and marketed by Kenvue. It is a combination product containing two active ingredients: tetrahydrozoline hydrochloride, a small molecule alpha-1 adrenergic receptor agonist, and zinc sulfate, an astringent. Tetrahydrozoline acts as a vasoconstrictor by constricting the superficial blood vessels in the conjunctiva, thereby temporarily reducing eye redness. Zinc sulfate functions as an astringent to help relieve irritation and clear mucus from the outer surface of the eye. This combination is indicated for the temporary relief of discomfort and redness due to minor eye irritations, including symptoms such as itchy, red, and watery eyes.

Brand names
Visine A.C.Visine A.C. Itchy Eye Relief
Other names
tetrahydrozoline hydrochloride + zinc sulfatetetrahydrozoline + zinc sulfate
02

Targets

ADRA2A (α2A)ADRA2C (α2C)ADRA1A (α1A)

Beyond the preview

Go deeper on Visine A.C..

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Visine A.C..

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call